Cargando…

Increased Thromboxane A(2) Levels in Pulmonary Artery Smooth Muscle Cells Isolated from Patients with Chronic Obstructive Pulmonary Disease

Introduction: Pulmonary hypertension due to chronic obstructive pulmonary disease (COPD) is classified as Group 3 pulmonary hypertension, with no current proven targeted therapies. It has been shown that cigarette smoke, the main risk factor for COPD, can increase thromboxane A(2) production in heal...

Descripción completa

Detalles Bibliográficos
Autor principal:	Alqarni, Abdullah A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861639/ https://www.ncbi.nlm.nih.gov/pubmed/36676790 http://dx.doi.org/10.3390/medicina59010165

Ejemplares similares

Thromboxane promotes smooth muscle phenotype commitment but not remodeling of hypoxic neonatal pulmonary artery
por: Postolow, Fabiana, et al.
Publicado: (2015)

Roles of airway smooth muscle dysfunction in chronic obstructive pulmonary disease
por: Yan, Furong, et al.
Publicado: (2018)

Effect of Fenspiride on Bronchial Smooth Muscle of Rats with Chronic Obstructive Pulmonary Disease
por: Kuzubova, Nataliya A., et al.
Publicado: (2013)

The bifunctional effect of propofol on thromboxane agonist (U46619)-induced vasoconstriction in isolated human pulmonary artery
por: Hao, Ning, et al.
Publicado: (2017)

The Role and Regulation of Pulmonary Artery Smooth Muscle Cells in Pulmonary Hypertension
por: He, Shixin, et al.
Publicado: (2020)

Regarding “Isolated large vessel pulmonary vasculitis and chronic obstruction of the pulmonary arteries”
por: Joob, Beuy, et al.
Publicado: (2012)

Furegrelate, a thromboxane synthase inhibitor, blunts the development of pulmonary arterial hypertension in neonatal piglets
por: Hirenallur-S., Dinesh K., et al.
Publicado: (2012)

Isolated large vessel pulmonary vasculitis as a cause of chronic obstruction of the pulmonary arteries
por: Hagan, Guy, et al.
Publicado: (2011)

Regulation of Pulmonary Vascular Smooth Muscle Contractility in Pulmonary Arterial Hypertension: Implications for Therapy
por: Lyle, Melissa A., et al.
Publicado: (2017)

Effect of EZH2 on pulmonary artery smooth muscle cell migration in pulmonary hypertension
por: Wang, Ying, et al.
Publicado: (2021)

Dexamethasone induces apoptosis in pulmonary arterial smooth muscle cells
por: Price, Laura C., et al.
Publicado: (2015)

Effects of dexmedetomidine on porcine pulmonary artery vascular smooth muscle
por: Chikuda, Mami, et al.
Publicado: (2019)

Intracellular iron deficiency in pulmonary arterial smooth muscle cells induces pulmonary arterial hypertension in mice
por: Lakhal-Littleton, Samira, et al.
Publicado: (2019)

Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt‐related pulmonary arterial hypertension
por: Zhou, Jing‐jing, et al.
Publicado: (2022)

Serum levels of biomarkers that may link chronic obstructive pulmonary disease and depressive disorder
por: Małujło-Balcerska, Elżbieta, et al.
Publicado: (2023)

NTP42, a novel antagonist of the thromboxane receptor, attenuates experimentally induced pulmonary arterial hypertension
por: Mulvaney, Eamon P., et al.
Publicado: (2020)

Skeletal muscle dysfunction in chronic obstructive pulmonary disease
por: Jeffery Mador, M, et al.
Publicado: (2001)

Muscle-Bone Crosstalk in Chronic Obstructive Pulmonary Disease
por: Zhang, Lijiao, et al.
Publicado: (2021)

Comparison of arterial and venous blood biomarker levels in chronic obstructive pulmonary disease
por: Kelly, Emer, et al.
Publicado: (2013)

Headache in patients with chronic obstructive pulmonary disease: effects of chronic hypoxaemia
por: Özge, A., et al.
Publicado: (2006)

Progenitor cell mobilisation and recruitment in pulmonary arteries in chronic obstructive pulmonary disease
por: Tura-Ceide, Olga, et al.
Publicado: (2019)

Pharmacological Alteration of Cellular Mechanical Properties in Pulmonary Arterial Smooth Muscle Cells of Idiopathic Pulmonary Arterial Hypertension
por: Katsuragi, Shinichi, et al.
Publicado: (2021)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Chen, Yong-Jie, et al.
Publicado: (2021)

Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt‐induced pulmonary arterial hypertension
por: Zhou, Jingjing
Publicado: (2022)

Spontaneous globe luxation associated with chronic obstructive pulmonary disease
por: Kumar, M Ashok, et al.
Publicado: (2012)

Lumbar hernia associated with chronic obstructive pulmonary disease (COPD)
por: Xu, Tao, et al.
Publicado: (2013)

Severity of Anxiety Disorders in Patients with Chronic Obstructive Pulmonary Disease
por: Safa, Mitra, et al.
Publicado: (2015)

Role of smooth muscle cell p53 in pulmonary arterial hypertension
por: Wakasugi, Takayuki, et al.
Publicado: (2019)

Endogenous Estrogen Attenuates Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Vasoconstriction and Pulmonary Arterial Smooth Muscle Cells Proliferation
por: Xu, Dunquan, et al.
Publicado: (2013)

Crucial role of RAGE in inappropriate increase of smooth muscle cells from patients with pulmonary arterial hypertension
por: Nakamura, Kazufumi, et al.
Publicado: (2018)

Oxidative stress–induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease
por: Wiegman, Coen H., et al.
Publicado: (2015)

Association between Serum Levels of Interleukin-25/Thymic Stromal Lymphopoietin and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease
por: Choi, Joon Young, et al.
Publicado: (2023)

Participation of PLK1 and FOXM1 in the hyperplastic proliferation of pulmonary artery smooth muscle cells in pulmonary arterial hypertension
por: Wilson, Jamie L., et al.
Publicado: (2019)

Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease
por: Kim, Ho Cheol, et al.
Publicado: (2008)

Respiratory Muscle Strength in Patients With Chronic Obstructive Pulmonary Disease
por: Kim, Nam-Sik, et al.
Publicado: (2017)

Muscle Wasting in Chronic Obstructive Pulmonary Disease: Not Enough Autophagy?
por: Leduc-Gaudet, Jean-Philippe, et al.
Publicado: (2022)

Zinc-mediated activation of CREB pathway in proliferation of pulmonary artery smooth muscle cells in pulmonary hypertension
por: Xiao, Genfa, et al.
Publicado: (2021)

Chronic obstructive pulmonary disease: Is serum magnesium level a risk factor for its acute exacerbation?
por: Kshirsagar, Ketan, et al.
Publicado: (2021)

Pulmonary artery stiffness in chronic obstructive pulmonary disease (copd) - the mesa copd study
por: Liu, Chia-Ying, et al.
Publicado: (2011)

Use of Tadalafil for Treating Pulmonary Arterial Hypertension Secondary to Chronic Obstructive Pulmonary Disease
por: Kim, Hyun-Sook, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_a0n86jdgplervc7fncggj47s6r